Breye Therapeutics has reported promising results from a clinical trial involving 24 patients with non-proliferative diabetic retinopathy who received the orally-administered treatment, danegaptide.

A new report has been published outlining the views of a diverse group of 65 Londoners on elective eye care. Patient choice in elective eye care was funded by NHS England and commissioned by North ...

Following a review by the Haute Autorité de santé [French National Authority for Health], children with severe myopia between the ages of five and 16 will become eligible for funded Miyosmart ...

The MyDryEye app, developed by an Aston University spinout company, provides blinking exercises to help patients manage their ...

Patient involvement, a focus on partnerships, and a need to demonstrate value: OT gathered six key insights from the NHS ...

Euromonitor International has released its latest report on the eyewear market in the UK. OT heard from Natasha Cazin, senior ...

The Retina UK Professionals’ Conference on 19 September will include content for eye care professionals, eye clinic liaison ...

EssilorLuxottica and Meta Platforms have announced plans to launch a new line of performance eyewear with artificial ...

The chief executive of the NHS Confederation praised an optometry-led High Street glaucoma service during the organisation’s ...